Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases.
about
Lethal ingestion of Chinese herbal tea containing ch'an su.An anti-hapten camelid antibody reveals a cryptic binding site with significant energetic contributions from a nonhypervariable loopTrial watch: Cardiac glycosides and cancer therapyMild hyperkalemia and low eGFR a tedious recipe for cardiac disaster in the elderly: an unusual reversible cause of syncope and heart block.Analysis of the use of digoxin immune fab for the treatment of non-life-threatening digoxin toxicity.Digitalis--a bicentennial progress report.Plasma digoxin: assay anomalies in Fab-treated patientsAntidote use in the critically ill poisoned patient.Hyperkalemia in the elderly: drugs exacerbate impaired potassium homeostasis.Calcium and cardiac arrhythmias: DADs, EADs, and alternans.Chronic anti-phencyclidine monoclonal antibody therapy decreases phencyclidine-induced in utero fetal mortality in pregnant rats.The influence of digoxin antibodies on digoxin disposition and effect: studies in guinea-pigs and HeLa cells.Use of digoxin-specific antibody fragments (Fab) in the management of digoxin poisoningMedical applications of single-chain antibodies.Assessment of digoxin antibody use in patients with elevated serum digoxin following chronic or acute exposure.Digitalis intoxication recognition and management.Incidence of immediate hypersensitivity reaction and serum sickness following administration of Crotalidae polyvalent immune Fab antivenom: a meta-analysis.Recrudescent digoxin toxicity treated with plasma exchange: a case report and review of literature.Autoimmunity: attack, or defence? (The case for a primary lesion theory).Digoxin-specific antibody fragments in the treatment of digoxin toxicity.Diagnosis and treatment of digoxin toxicity.Antibody-based therapies as anti-infective agents.Antibody-based therapies for emerging infectious diseases.New advances in the assessment and treatment of digitalis toxicity.Management of atrial fibrillation and flutter. A reappraisal of digitalis therapy.Enhancement of xenobiotic elimination: role of intestinal excretion.Disturbances of potassium homeostasis in poisoning.Pharmacokinetics and efficacy of digoxin specific Fab fragments in a child following massive digoxin overdose.Use of amiodarone and digoxin specific Fab antibodies in digoxin overdosage.Reduction of toxicity of a vinca alkaloid by an anti-vinca alkaloid antibody.Monoclonal antibodies in diagnosis and treatmentDigitalis intoxication: a new approach to an old problem.Tolerance to rat monoclonal antibodies. Implications for serotherapy.Influence of assay methods on serum concentrations of digoxin during FAB fragment treatment.Elderly patients with suspected chronic digoxin toxicity: A comparison of clinical characteristics of patients receiving and not receiving digoxin-Fab.Digoxin-specific antibody fragments and a calcium antagonist for reversal of digoxin-induced mesenteric vasoconstriction.Digoxin assay anomalies due to digoxin-specific Fab immunotherapy.Increased plasma paraquat levels in intoxicated mice following antiparaquat F(ab')2 treatment.Poster Communications
P2860
Q24537681-436922AC-D369-42F7-9AFB-65FF5E11CE25Q27667776-05BB9375-79E0-45A0-9B76-041A1DE2A0EAQ28395830-565F7587-DE2E-451E-B00D-03277BA46095Q33160624-FDC85B56-6843-4783-A835-DBF69E6BE4CEQ33930768-9B41F02E-379A-4074-97B8-216D583A177EQ34194028-9E212205-B6C0-423E-A8E2-77BCDAABBADFQ34513271-95938B07-BABA-41F6-9AEB-07686E3785B6Q34562529-72227167-CD0A-44F5-A750-A0034BF8A6DDQ34753785-0027C752-1AC4-4494-B68F-375C2D6479EDQ35189269-8A2BE7A3-4511-4FB1-BE10-959D9EAA7CF7Q35773781-AA9D764F-6192-458C-A1E8-A2B8ADF36311Q36004317-47D04936-1BCC-43DB-9FE7-C34977133921Q36749919-3745110E-976C-43FC-94FA-AA7245C4E7C9Q36767989-278EB3A3-929F-4406-B9B1-A874DFE89849Q37128780-AACB6408-3FF7-4392-86BF-9951A5B20AD9Q37761271-B248BFCD-C141-4291-B3C5-D0B675824CF1Q37982782-E7CDCA0D-9E0C-47C5-9DCD-8626400C195FQ38012358-29DEF4DA-7042-404B-846A-18DA12812BFAQ38219248-AA408959-CAED-4ABC-8D29-27AE91EBCC7FQ38236647-14C6E7D3-F316-4289-A573-DAD6103C6DACQ38662296-1793E4E7-E74D-4858-AA57-F175865F2DB8Q39216839-C840BF73-1F3A-40B1-BE33-546584E5505DQ39228846-8D3152B9-38AE-4FF8-B800-2BA94476FD24Q39497790-B620DC85-B7ED-4159-B8D6-FF294EDA3DA9Q39734523-78A8094A-A90F-45C3-BB51-E8E8272F1452Q40200353-CDA317AE-D320-4DB2-A05D-6DEB05F5CA1CQ40457220-77157C98-30E4-4F1D-A36A-0DEB838CFFD5Q40770815-22C8F0B9-6F9A-437D-A668-4956479B9B6EQ41309428-DB903793-2260-475D-849B-F258AA027BC6Q41399894-9365CAB3-6F07-46E3-ADE5-7566016324EFQ41933230-5358B9C8-32CD-48A7-A044-55CEA07B6FD3Q42784739-EF1C4293-B2D3-416D-B635-D04240611700Q42938072-569A79C2-172C-4BFF-BEB5-740F21BB5E59Q44761247-E7F00279-73A5-4C06-9C9D-F704754D9A64Q47188720-66B21BB4-508B-4AB3-941F-55F6464DCD23Q51851613-CB7F3F35-7727-472B-95C4-C2ED52CC7F06Q52049740-6BCCFE52-5C85-4C75-BD9E-67AC6C1327DFQ53743393-CD802C17-0983-40DD-8971-23FDAB6FF61FQ58830772-1AB9A6C8-B5E9-479A-AA7E-900A0BFD4527
P2860
Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh
1982年學術文章
@zh-hant
name
Treatment of life-threatening ...... ments: experience in 26 cases.
@en
Treatment of life-threatening ...... ments: experience in 26 cases.
@nl
type
label
Treatment of life-threatening ...... ments: experience in 26 cases.
@en
Treatment of life-threatening ...... ments: experience in 26 cases.
@nl
prefLabel
Treatment of life-threatening ...... ments: experience in 26 cases.
@en
Treatment of life-threatening ...... ments: experience in 26 cases.
@nl
P2093
P921
P1476
Treatment of life-threatening ...... ments: experience in 26 cases.
@en
P2093
Bremner WF
Butler VP Jr
Phillips A
Schulman IC
P304
P356
10.1056/NEJM198211253072201
P407
P577
1982-11-01T00:00:00Z